4-(4-Amino-3,5-dimethylphenyl)-2,6-dimethylaniline;hydron;dichloride

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(4-Amino-3,5-dimethylphenyl)-2,6-dimethylaniline;hydron;dichloride
• 化学式: C16H22Cl2N2
• 分子量: 313.3
• InChiKey: NYNRGZULARUZCC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  20
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  52
• 氢给体数：
  4
• 氢受体数：
  2

文献信息

• [EN] PHOTOALIGNING MATERIALS<br/>[FR] MATÉRIAUX DE PHOTOALIGNEMENT
  申请人：ROLIC AG

  公开号：WO2013050121A1

  公开（公告）日：2013-04-11

  The present invention relates to polymer, homo- or copolymer or oligomer for the photoalignment of liquid crystals, especially for the planar orientation of liquid crystals, comprising a main chain and a side chain, wherein the side chain and/or main chain comprises a polar group, compositions thereof, and its use for optical and electro optical devices, especially liquid crystal devices (LCDs).

  本发明涉及用于液晶的光调向的聚合物、同聚物或寡聚物，特别用于液晶的平面取向，包括主链和侧链，其中侧链和/或主链包含极性基团，以及其组合物，以及其在光学和电光设备中的应用，特别是液晶设备（LCD）。
• Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof
  申请人：Tsou Hwei-Ru

  公开号：US20080085890A1

  公开（公告）日：2008-04-10

  This invention provides compounds of Formula (I), having the structure where G 1 , G 2 , G 3 , G 4 , A 1 , A 2 , Y 1 , Y 2 , L 1 , Z, e and f are defined herein, or a pharmaceutically acceptable salt thereof, which are useful for treating or preventing cancer.

  这项发明提供了具有结构的化合物（I），其中G1、G2、G3、G4、A1、A2、Y1、Y2、L1、Z、e和f在此处定义，或其药用可接受盐，用于治疗或预防癌症。
• Quantification of hydrogen peroxyde by triggered reconstitution of horseradish peroxidase using a modified hemin
  申请人：Universität Heidelberg

  公开号：EP1990347A1

  公开（公告）日：2008-11-12

  The present invention relates to specific hemin derivatives, a kit comprising these hemin derivatives in combination with apo-horseradish peroxidase (apo-HRP), and an assay method for detecting and/or quantifying an analyte in a biological sample which comprises detecting hydrogen peroxide generated in the presence as opposed to the absence of said analyte by bringing said sample into contact with such a kit.

  本发明涉及特定的血红素衍生物，一种包含这些血红素衍生物与去乙酰辣根过氧化物酶（apo-HRP）结合的试剂盒，以及一种用于检测和/或定量生物样本中分析物的测定方法，该方法包括通过将样本与该试剂盒接触来检测在有分析物存在的情况下与不存在的情况相对生成的过氧化氢。
• Method for immunologically measuring RCAS1 and kit for measuring the same
  申请人：——

  公开号：US20030022259A1

  公开（公告）日：2003-01-30

  RCAS1 in a specimen is measured by a immunoglogically method consisting of a step of reacting a specimen with a first anti-RCAS1 antibody capable of specifically binding to RCAS1, a step of labeling the first reaction product produced by the aforementioned step, and a step of measuring a labeled amount of the labeled first reaction product. As RCAS1, recombinant RCAS1 is used. In addition, as a first anti-RCAS1, a monoclonal antibody derived from the SiSo cell line is used.

  样本中的RCAS1是通过免疫学方法测量的，包括以下步骤：将样本与第一抗RCAS1抗体反应，该抗体能够特异性地结合到RCAS1上；标记由上述步骤产生的第一反应产物；测量标记的第一反应产物的标记量。作为RCAS1，使用重组RCAS1。此外，作为第一抗RCAS1，使用从SiSo细胞系中分离的单克隆抗体。
• Fibrinogen receptor antagonists and their use
  申请人：Lal Bansi

  公开号：US20070021489A1

  公开（公告）日：2007-01-25

  This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.

  本发明涉及一种新型的融合双环化合物，其一般式为(I)：其中符号在此定义，以及包含该化合物的制药组合物、制备该化合物的方法和使用该化合物的方法，单独或与其他治疗剂联合使用。该化合物是血小板糖蛋白IIb/IIIa纤维蛋白原受体复合物的拮抗剂，因此对于抑制血小板聚集和治疗血栓性疾病和其他疾病非常有用。

表征谱图